FDA Releases Guidance on Citizen Petitions and Petitions for Stay of Action Subject to Section 505(q) of the Federal Food, Drug, and Cosmetic Act

Summary

The Food and Drug Administration (FDA) has published a guidance document outlining its procedures for handling citizen petitions and petitions for stay of action related to new drug applications, following changes made by the Food and Drug Administration Amendments Act (FDAAA)